Found: 4
Select item for more details and to access through your institution.
p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans.
- Published in:
- Diabetologia, 2015, v. 58, n. 10, p. 2352, doi. 10.1007/s00125-015-3667-8
- By:
- Publication type:
- Article
Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet.
- Published in:
- Acta Neuropathologica, 2016, v. 132, n. 1, p. 127, doi. 10.1007/s00401-016-1550-4
- By:
- Publication type:
- Article
Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients.
- Published in:
- Frontiers in Physiology, 2018, p. 1, doi. 10.3389/fphys.2018.01087
- By:
- Publication type:
- Article
Comparative Analysis of Muscle Hypertrophy Models Reveals Divergent Gene Transcription Profiles and Points to Translational Regulation of Muscle Growth through Increased mTOR Signaling.
- Published in:
- Frontiers in Physiology, 2017, p. 1, doi. 10.3389/fphys.2017.00968
- By:
- Publication type:
- Article